The effects of restricting publicly subsidised temazepam capsules on benzodiazepine use among injecting drug users in Australia

Medical Journal of Australia

Volumn 181, Issue 6, 2004, Pages 300-304

  Breen, Courtney L ^a   Degenhardt, Louisa J ^a   Bruno, Raimondo B ^b   Roxburgh, Amanda D ^a   Jenkinson, Rebecca ^c  

^a UNIVERSITY OF NEW SOUTH WALES   (Australia)

^b UNIVERSITY OF TASMANIA   (Australia)

^c Turning Point Alcohol Drug Ctr Inc   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ALPRAZOLAM; BENZODIAZEPINE; DIAMORPHINE; DIAZEPAM; FLUNITRAZEPAM; METHADONE; MORPHINE; OPIATE; TEMAZEPAM;

ARTICLE; AUSTRALIA; DRUG CAPSULE; DRUG DEPENDENCE; DRUG LEGISLATION; DRUG MISUSE; DRUG TARGETING; DRUG USE; HEALTH CARE POLICY; HEALTH SERVICE; HEALTH SURVEY; HUMAN; INJECTION; MEDICAL ASSESSMENT; MEDICAL EDUCATION; MEDICAL PRACTICE; PHYSICIAN; PRESCRIPTION; PREVALENCE; TABLET FORMULATION; TIME SERIES ANALYSIS;

EID: 4644368828     PISSN: 0025729X     EISSN: None     Source Type: Journal    
DOI: 10.5694/j.1326-5377.2004.tb06293.x     Document Type: Article

References (18)

1. Darke S. The use of benzodiazepines among injecting drug users. Drug Alcohol Rev 1994; 13: 63-69.
2. Ross J, Darke S. The nature of benzodiazepine dependence among heroin users in Sydney, Australia. Addiction 2000; 95: 1785-1793.
3. Strang J, Griffiths P, Abbey J, Gossop M. Survey of injected benzodiazepines among drug users in Britain. BMJ 1994; 308: 1082.
4. Dupont RL. Abuse of benzodiazepines: the problems and the solutions. Am J Drug Alcohol Abuse 1998; 14(Suppl 1): 1-69.
5. Iguchi MY, Handelsman L, Bickel WK, Griffiths RR. Benzodiazepine and sedative use/abuse by methadone maintenance clients. Drug Alcohol Depend 1993; 32: 257-266.
6. Gelkopf M, Bleich A, Hayward R, et al. Characteristics of benzodiazepine abuse in methadone maintenance treatment patients: a 1 year prospective study in an Israeli clinic. Drug Alcohol Depend 1999; 55: 63-68.
7. Klee H, Fluagier J, Hayes C, et al. AIDS-related risk behaviour, polydrug use and temazepam. Br J Addiction 1990; 85: 1125-1132.
8. Ross J, Darke S, Hall W. Benzodiazepine use among heroin users in Sydney: patterns of use, availability and procurement. Drug Alcohol Rev 1996; 15: 237-243.
9. Gutierrez-Cedollada J, De La Torre R, Ortuño J, et al. Psychotropic drug consumption and other factors associated with heroin overdose. Drug Alcohol Depend 1994; 35: 169-174.
10. Eddey DP, Westcott MJ. 'The needle and the damage done': Intra-arterial temazepam. Emerg Med 2000; 12: 248-252.
11. Fry C, Bruno R. Recent trends in benzodiazepine use by injecting drug users in Victoria and Tasmania. Drug Alcohol Rev 2002; 21: 363-367.
12. Topp L, Kaye S, Bruno R, et al. Australian Drug Trends 2001. Findings from the Illicit Drug Reporting System (IDRS). Sydney: National Drug and Alcohol Research Centre, University of New South Wales; 2002. (NDARC Monograph Number 48.)
13. Commonwealth Department of Health and Ageing. Australian Statistics on Medicines, 1999-2000. Canberra: Commonwealth Department of Health and Ageing; 2003.
14. Sayer GP, McGeechan K, Kemp A, et al. The General Practice Research Network: the capabilities of an electronic patient management system for longitudinal patient data. Pharmacoepidemiol Drug Saf 2003; 12: 483-489.
15. Box G, Jenkins G. Time series analysis: forecasting and control. San Francisco: Holden-Day; 1976.
16. SPSS for Windows [computer program]. Version 11.0. Chicago, Ill: SPSS Inc, 1996.
17. Feeney G, Gibbs H. Digit loss following misuse of temazepam. Med J Aust 2002; 176: 380.
18. Darke S, Ross J, Teesson M, Lynskey M. Health service utilisation and benzodiazepine use among heroin users: findings from the Australian Treatment Outcome Study (ATOS). Addiction 2003; 98: 1129-1135.